InsiderTrades.com logo

TVTX Insider Trading

Insider Ownership Percentage: 4.06%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $22,322,814.44

Travere Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Travere Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Travere Therapeutics Share Price & Price History

Current Price: $32.84
Price Change: ▼ Price Decrease of -0.26 (-0.79%)
As of 02/3/2026 05:00 PM ET

This chart shows the closing price history over time for TVTX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Travere Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/3/2026Christopher R. ClineCFOSell7,242$32.12$232,613.04112,971View SEC Filing Icon  
2/3/2026Elizabeth E. ReedInsiderSell7,175$32.12$230,461.00108,205View SEC Filing Icon  
2/3/2026Eric M. DubeCEOSell100,087$32.28$3,230,808.36432,886View SEC Filing Icon  
2/3/2026Jula InrigInsiderSell6,956$32.12$223,426.72107,485View SEC Filing Icon  
2/3/2026Peter HeermaInsiderSell7,310$32.12$234,797.20131,823View SEC Filing Icon  
2/3/2026Sandra CalvinCAOSell4,333$32.12$139,175.9649,080View SEC Filing Icon  
2/3/2026William E. RoteInsiderSell12,446$32.87$409,100.02109,087View SEC Filing Icon  
1/27/2026Eric M. DubeCEOSell51,865$30.10$1,561,136.50419,173View SEC Filing Icon  
1/23/2026Eric M. DubeCEOSell8,135$30.01$244,131.35419,173View SEC Filing Icon  
1/20/2026Elizabeth E. ReedInsiderSell10,000$27.34$273,400.0090,270View SEC Filing Icon  
1/6/2026Jula InrigInsiderSell445$37.75$16,798.7586,311View SEC Filing Icon  
1/5/2026Jula InrigInsiderSell2,031$40.18$81,605.5886,756View SEC Filing Icon  
12/24/2025Jula InrigInsiderSell15,000$42.00$630,000.0088,787View SEC Filing Icon  
12/24/2025Peter HeermaInsiderSell4,980$40.00$199,200.00113,013View SEC Filing Icon  
12/24/2025Sandra CalvinCAOSell7,402$40.00$296,080.0038,233View SEC Filing Icon  
12/24/2025William E. RoteInsiderSell60,000$40.10$2,406,000.00101,443View SEC Filing Icon  
12/1/2025Christopher R. ClineCFOSell20,000$35.01$700,200.0092,083View SEC Filing Icon  
11/4/2025Sandra CalvinCAOSell67,115$36.00$2,416,140.0048,545View SEC Filing Icon  
10/31/2025Peter HeermaInsiderSell5,591$35.00$195,685.00119,071View SEC Filing Icon  
10/31/2025Timothy CoughlinDirectorSell18,000$35.03$630,540.0055,500View SEC Filing Icon  
10/29/2025Eric M. DubeCEOSell27,128$30.12$817,095.36419,173View SEC Filing Icon  
10/28/2025Eric M. DubeCEOSell92,872$30.38$2,821,451.36419,173View SEC Filing Icon  
10/28/2025Peter HeermaInsiderSell2,662$30.00$79,860.00124,662View SEC Filing Icon  
9/22/2025Elizabeth E. ReedInsiderSell10,000$25.00$250,000.0089,878View SEC Filing Icon  
9/4/2025Christopher R. ClineCFOSell119$19.71$2,345.4992,083View SEC Filing Icon  
9/3/2025Christopher R. ClineCFOSell454$18.20$8,262.8092,202View SEC Filing Icon  
7/1/2025Jula InrigInsiderSell815$14.65$11,939.7588,787View SEC Filing Icon  
5/5/2025Christopher R. ClineCFOSell1,784$21.05$37,553.2093,126View SEC Filing Icon  
5/5/2025Eric M. DubeCEOSell18,924$21.05$398,350.20419,173View SEC Filing Icon  
5/5/2025Peter HeermaInsiderSell1,771$21.05$37,279.55128,215View SEC Filing Icon  
4/11/2025Christopher R. ClineCFOSell48$13.14$630.7289,990View SEC Filing Icon  
2/12/2025William E. RoteSVPSell5,200$23.53$122,356.0098,519View SEC Filing Icon  
2/11/2025Eric M. DubeCEOSell11,375$24.04$273,455.00419,173View SEC Filing Icon  
2/11/2025Peter HeermaInsiderSell3,074$25.00$76,850.00127,634View SEC Filing Icon  
2/11/2025Sandra CalvinCAOSell54,244$25.00$1,356,100.0054,410View SEC Filing Icon  
2/6/2025Roy D. BaynesDirectorSell10,000$22.00$220,000.0031,000View SEC Filing Icon  
2/3/2025Christopher R. ClineCFOSell5,192$20.12$104,463.0490,038View SEC Filing Icon  
2/3/2025Eric M. DubeCEOSell50,691$20.21$1,024,465.11430,548View SEC Filing Icon  
2/3/2025Jula InrigInsiderSell4,207$20.12$84,644.8485,236View SEC Filing Icon  
2/3/2025Sandra CalvinCAOSell3,348$20.12$67,361.7663,654View SEC Filing Icon  
2/3/2025William E. RoteSVPSell8,951$19.78$177,050.7895,719View SEC Filing Icon  
1/23/2025Roy D. BaynesDirectorSell16,000$20.00$320,000.0031,000View SEC Filing Icon  
1/22/2025Christopher R. ClineCFOSell865$18.94$16,383.1073,730View SEC Filing Icon  
1/22/2025Eric M. DubeCEOSell10,736$19.46$208,922.56351,239View SEC Filing Icon  
1/22/2025Peter HeermaInsiderSell1,584$18.94$30,000.96106,374View SEC Filing Icon  
1/22/2025Sandra CalvinCAOSell925$18.94$17,519.5054,002View SEC Filing Icon  
1/22/2025William E. RoteSVPSell2,437$19.46$47,424.0283,170View SEC Filing Icon  
1/6/2025Jula InrigInsiderSell440$18.76$8,254.4059,443View SEC Filing Icon  
1/3/2025Jula InrigInsiderSell2,066$19.10$39,460.6059,883View SEC Filing Icon  
12/26/2024Sandra CalvinCAOSell15,000$17.22$258,300.0054,927View SEC Filing Icon  
11/25/2024Sandra CalvinCAOSell12,090$18.30$221,247.0054,927View SEC Filing Icon  
10/4/2024Gary A LyonsDirectorSell40,000$14.73$589,200.0051,000View SEC Filing Icon  
9/30/2024Jeffrey A MecklerDirectorSell40,000$14.06$562,400.0081,000View SEC Filing Icon  
9/9/2024Christopher R. ClineCFOSell2,490$11.52$28,684.8074,595View SEC Filing Icon  
9/9/2024Eric M. DubeCEOSell21,125$11.52$243,360.00361,975View SEC Filing Icon  
9/9/2024Jula InrigInsiderSell2,191$11.52$25,240.3262,633View SEC Filing Icon  
9/9/2024William E. RoteSVPSell4,387$11.52$50,538.2484,455View SEC Filing Icon  
9/4/2024Christopher R. ClineCFOSell514$9.51$4,888.1470,335View SEC Filing Icon  
4/11/2024Christopher R. ClineCFOSell54$6.74$363.9670,849View SEC Filing Icon  
2/1/2024Christopher R. ClineCFOSell3,818$8.53$32,567.5470,903View SEC Filing Icon  
2/1/2024Eric M. DubeCEOSell19,122$8.70$166,361.40350,600View SEC Filing Icon  
2/1/2024Peter HeermaInsiderSell4,195$8.53$35,783.3599,503View SEC Filing Icon  
2/1/2024Sandra CalvinCAOSell2,820$8.53$24,054.6052,017View SEC Filing Icon  
2/1/2024William E. RoteSVPSell4,764$8.71$41,494.4480,720View SEC Filing Icon  
1/23/2024Christopher R. ClineCFOSell853$9.07$7,736.7149,721View SEC Filing Icon  
1/23/2024Elizabeth E. ReedSVPSell2,062$8.96$18,475.5256,034View SEC Filing Icon  
1/23/2024Eric M. DubeCEOSell7,873$8.96$70,542.08234,722View SEC Filing Icon  
1/23/2024Peter HeermaInsiderSell1,559$9.07$14,140.1378,698View SEC Filing Icon  
1/23/2024Sandra CalvinCAOSell910$9.07$8,253.7041,337View SEC Filing Icon  
1/3/2024Jula InrigInsiderSell2,069$9.48$19,614.1235,688View SEC Filing Icon  
10/3/2023Peter HeermaInsiderSell3,091$8.25$25,500.7580,257View SEC Filing Icon  
9/5/2023Christopher R. ClineCFOSell457$14.71$6,722.4750,574View SEC Filing Icon  
9/5/2023Eric M. DubeCEOSell4,455$14.71$65,533.05242,595View SEC Filing Icon  
9/5/2023William E. RoteSVPSell1,815$14.71$26,698.6561,173View SEC Filing Icon  
5/10/2023Christopher R. ClineCFOSell455$16.59$7,548.4551,031View SEC Filing Icon  
5/10/2023Elizabeth E. ReedSVPSell825$16.59$13,686.7556,611View SEC Filing Icon  
5/10/2023Sandra CalvinCAOSell436$16.59$7,233.2442,369View SEC Filing Icon  
4/11/2023Christopher R. ClineCFOSell47$21.49$1,010.0351,486View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Travere Therapeutics (NASDAQ:TVTX)

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at TVTX by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Travere Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/3/2026F m Investments LLC168,416$6.44M0.2%-14.1%0.188%Search for SEC Filing on Google Icon
2/3/2026RFG Advisory LLC42,727$1.63M0.0%N/A0.048%Search for SEC Filing on Google Icon
2/3/2026Garner Asset Management Corp1,800$69K0.0%N/A0.002%Search for SEC Filing on Google Icon
2/2/2026Hussman Strategic Advisors Inc.31,500$1.20M0.3%-25.0%0.035%Search for SEC Filing on Google Icon
2/2/2026Oppenheimer Asset Management Inc.5,566$0.21M0.0%N/A0.006%Search for SEC Filing on Google Icon
1/30/2026Jennison Associates LLC256,335$9.80M0.0%-76.4%0.287%Search for SEC Filing on Google Icon
1/30/2026State of New Jersey Common Pension Fund D28,904$1.10M0.0%N/A0.032%Search for SEC Filing on Google Icon
1/30/2026Torren Management LLC998$38K0.0%N/A0.001%Search for SEC Filing on Google Icon
1/30/2026M&T Bank Corp11,682$0.45M0.0%N/A0.013%Search for SEC Filing on Google Icon
1/29/2026Comerica Bank1,127$43K0.0%+77.5%0.001%Search for SEC Filing on Google Icon
1/29/2026Pictet Asset Management Holding SA534,614$20.78M0.0%-21.9%0.598%Search for SEC Filing on Google Icon
1/29/2026UBS Group AG422,619$16.15M0.0%-29.1%0.472%Search for SEC Filing on Google Icon
1/29/2026Teachers Retirement System of The State of Kentucky24,917$0.95M0.0%-18.7%0.028%Search for SEC Filing on Google Icon
1/29/2026Vanguard Group Inc.6,309,229$241.08M0.0%-4.6%7.052%Search for SEC Filing on Google Icon
1/29/2026Impax Asset Management Group plc225,000$8.60M0.1%-52.6%0.251%Search for SEC Filing on Google Icon
1/29/2026Concurrent Investment Advisors LLC11,467$0.44M0.0%N/A0.013%Search for SEC Filing on Google Icon
1/29/2026Calamos Advisors LLC72,305$2.76M0.0%N/A0.081%Search for SEC Filing on Google Icon
1/29/2026China Universal Asset Management Co. Ltd.15,079$0.58M0.0%-3.5%0.017%Search for SEC Filing on Google Icon
1/28/2026Arizona State Retirement System23,411$0.90M0.0%-6.2%0.026%Search for SEC Filing on Google Icon
1/28/2026Universal Beteiligungs und Servicegesellschaft mbH202,222$7.73M0.0%-5.5%0.226%Search for SEC Filing on Google Icon
1/27/2026Zurcher Kantonalbank Zurich Cantonalbank 30,877$1.18M0.0%+20.9%0.035%Search for SEC Filing on Google Icon
1/27/2026First Horizon Corp3,236$0.12M0.0%+112.1%0.004%Search for SEC Filing on Google Icon
1/26/2026Mirae Asset Global Investments Co. Ltd.4,348$0.17M0.0%+26.2%0.005%Search for SEC Filing on Google Icon
1/26/2026CWM LLC12,819$0.49M0.0%+11.9%0.014%Search for SEC Filing on Google Icon
1/23/2026Oak Ridge Investments LLC66,383$2.54M0.2%-2.7%0.074%Search for SEC Filing on Google Icon
1/23/2026Assetmark Inc.21,567$0.82M0.0%N/A0.024%Search for SEC Filing on Google Icon
1/20/2026Palisades Investment Partners LLC137,768$5.26M2.0%N/A0.154%Search for SEC Filing on Google Icon
1/16/2026Aberdeen Group plc518,357$19.81M0.0%-46.4%0.579%Search for SEC Filing on Google Icon
1/14/2026Hennion & Walsh Asset Management Inc.99,229$3.79M0.1%+169.6%0.111%Search for SEC Filing on Google Icon
1/9/2026SG Americas Securities LLC34,100$1.30M0.0%-22.4%0.038%Search for SEC Filing on Google Icon
1/9/2026Assenagon Asset Management S.A.417,742$15.96M0.0%+347.5%0.467%Search for SEC Filing on Google Icon
1/9/2026Diversified Trust Co.25,044$0.96M0.0%+5.7%0.028%Search for SEC Filing on Google Icon
1/8/2026Wealth Enhancement Advisory Services LLC6,261$0.22M0.0%N/A0.007%Search for SEC Filing on Google Icon
1/1/2026Tudor Investment Corp ET AL95,747$2.29M0.0%-52.5%0.107%Search for SEC Filing on Google Icon
12/9/2025Tudor Investment Corp ET AL95,747$2.29M0.0%-52.5%0.107%Search for SEC Filing on Google Icon
11/24/2025Penn Capital Management Company LLC27,004$0.65M0.0%+39.7%0.030%Search for SEC Filing on Google Icon
11/21/2025CIBC Bancorp USA Inc.9,398$0.23M0.0%N/A0.011%Search for SEC Filing on Google Icon
11/17/2025Jacobs Levy Equity Management Inc.318,146$7.60M0.0%-56.7%0.356%Search for SEC Filing on Google Icon
11/17/2025Armistice Capital LLC6,724,000$160.70M2.4%-24.2%7.515%Search for SEC Filing on Google Icon
11/17/2025Woodline Partners LP89,328$2.14M0.0%-82.2%0.100%Search for SEC Filing on Google Icon
11/17/2025PDT Partners LLC281,458$6.73M0.4%-19.5%0.315%Search for SEC Filing on Google Icon
11/17/2025Dark Forest Capital Management LP28,483$0.68M0.0%-46.5%0.032%Search for SEC Filing on Google Icon
11/17/2025PharVision Advisers LLC8,799$0.21M0.1%N/A0.010%Search for SEC Filing on Google Icon
11/17/2025Voloridge Investment Management LLC883,672$21.12M0.1%+18.7%0.988%Search for SEC Filing on Google Icon
11/17/2025Quarry LP14,960$0.36M0.1%+113.7%0.017%Search for SEC Filing on Google Icon
11/17/2025Qube Research & Technologies Ltd571,997$13.67M0.0%-5.3%0.639%Search for SEC Filing on Google Icon
11/17/2025Prelude Capital Management LLC46,407$1.11M0.1%-5.4%0.052%Search for SEC Filing on Google Icon
11/17/2025Parkman Healthcare Partners LLC339,764$8.12M0.8%-58.9%0.380%Search for SEC Filing on Google Icon
11/17/2025Militia Capital Partners LP15,400$0.37M0.2%N/A0.017%Search for SEC Filing on Google Icon
11/17/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.45,573$1.09M0.0%-16.4%0.051%Search for SEC Filing on Google Icon
11/17/2025Jain Global LLC32,117$0.77M0.0%N/A0.036%Search for SEC Filing on Google Icon
11/17/2025Gotham Asset Management LLC27,743$0.66M0.0%N/A0.031%Search for SEC Filing on Google Icon
11/17/2025Fred Alger Management LLC122,029$2.92M0.0%N/A0.136%Search for SEC Filing on Google Icon
11/17/2025Brevan Howard Capital Management LP42,505$1.02M0.0%N/A0.048%Search for SEC Filing on Google Icon
11/17/2025Cinctive Capital Management LP94,656$2.26M0.1%N/A0.106%Search for SEC Filing on Google Icon
11/17/2025Algert Global LLC153,648$3.67M0.1%+20.8%0.172%Search for SEC Filing on Google Icon
11/17/2025Alliancebernstein L.P.322,115$7.70M0.0%-6.3%0.360%Search for SEC Filing on Google Icon
11/17/2025Apis Capital Advisors LLC166,000$3.97M0.9%N/A0.186%Search for SEC Filing on Google Icon
11/14/2025Schonfeld Strategic Advisors LLC16,872$0.40M0.0%-70.0%0.019%Search for SEC Filing on Google Icon
11/14/2025Creative Planning36,807$0.88M0.0%+16.4%0.041%Search for SEC Filing on Google Icon
11/14/2025Man Group plc29,727$0.71M0.0%-78.6%0.033%Search for SEC Filing on Google Icon
11/14/2025California State Teachers Retirement System79,936$1.91M0.0%+10.7%0.089%Search for SEC Filing on Google Icon
11/14/2025Fiduciary Trust Co9,461$0.23M0.0%N/A0.011%Search for SEC Filing on Google Icon
11/14/2025UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC145,927$3.49M0.0%-67.2%0.163%Search for SEC Filing on Google Icon
11/14/2025Two Sigma Investments LP928,998$22.20M0.0%+1.1%1.038%Search for SEC Filing on Google Icon
11/14/2025Squarepoint Ops LLC114,477$2.74M0.0%-76.1%0.128%Search for SEC Filing on Google Icon
11/14/2025Wellington Management Group LLP1,201,469$28.72M0.0%+3,331.9%1.343%Search for SEC Filing on Google Icon
11/14/2025F m Investments LLC196,074$4.69M0.2%+4.4%0.219%Search for SEC Filing on Google Icon
11/13/2025Jump Financial LLC315,030$7.53M0.1%N/A0.352%Search for SEC Filing on Google Icon
11/13/2025Marshall Wace LLP590,051$14.10M0.0%-20.6%0.659%Search for SEC Filing on Google Icon
11/13/2025Entropy Technologies LP16,793$0.40M0.0%N/A0.019%Search for SEC Filing on Google Icon
11/13/2025Arrowstreet Capital Limited Partnership328,654$7.86M0.0%N/A0.367%Search for SEC Filing on Google Icon
11/13/2025Invesco Ltd.627,902$15.01M0.0%+22.9%0.702%Search for SEC Filing on Google Icon
11/13/2025Sei Investments Co.49,432$1.18M0.0%-38.3%0.055%Search for SEC Filing on Google Icon
11/13/2025Connor Clark & Lunn Investment Management Ltd.857,899$20.50M0.1%+25.1%0.959%Search for SEC Filing on Google Icon
11/13/2025Capital Fund Management S.A.41,512$0.99M0.0%-59.1%0.046%Search for SEC Filing on Google Icon
11/13/2025BNP Paribas Financial Markets565,597$13.52M0.0%+223.1%0.632%Search for SEC Filing on Google Icon
11/13/2025Mackenzie Financial Corp50,370$1.20M0.0%-16.5%0.056%Search for SEC Filing on Google Icon
11/13/2025Franklin Resources Inc.34,724$0.83M0.0%-54.6%0.039%Search for SEC Filing on Google Icon
11/13/2025Quadrant Capital Group LLC6,622$0.16M0.0%N/A0.007%Search for SEC Filing on Google Icon
11/13/2025Legal & General Group Plc520,592$12.44M0.0%+2.0%0.582%Search for SEC Filing on Google Icon
11/13/2025Swiss National Bank163,600$3.91M0.0%+1.6%0.183%Search for SEC Filing on Google Icon
11/13/2025Russell Investments Group Ltd.222,257$5.31M0.0%-82.6%0.248%Search for SEC Filing on Google Icon
11/13/2025Schroder Investment Management Group62,293$1.50M0.0%-85.2%0.070%Search for SEC Filing on Google Icon
11/13/2025Inceptionr LLC10,487$0.25M0.1%N/A0.012%Search for SEC Filing on Google Icon
11/13/2025First Trust Advisors LP172,430$4.12M0.0%-27.9%0.193%Search for SEC Filing on Google Icon
11/12/2025Barclays PLC349,002$8.34M0.0%-52.4%0.390%Search for SEC Filing on Google Icon
11/12/2025GW&K Investment Management LLC117,869$2.82M0.0%-58.3%0.132%Search for SEC Filing on Google Icon
11/12/2025Legato Capital Management LLC71,030$1.70M0.2%N/A0.079%Search for SEC Filing on Google Icon
11/12/2025Teachers Retirement System of The State of Kentucky30,635$0.73M0.0%N/A0.034%Search for SEC Filing on Google Icon
11/12/2025Victory Capital Management Inc.45,535$1.09M0.0%+84.7%0.051%Search for SEC Filing on Google Icon
11/12/2025Fisher Asset Management LLC39,341$0.94M0.0%-8.9%0.044%Search for SEC Filing on Google Icon
11/12/2025Royce & Associates LP123,250$2.95M0.0%-67.7%0.138%Search for SEC Filing on Google Icon
11/12/2025Rafferty Asset Management LLC90,250$2.16M0.0%-27.1%0.101%Search for SEC Filing on Google Icon
11/12/2025Intech Investment Management LLC27,542$0.66M0.0%-29.4%0.031%Search for SEC Filing on Google Icon
11/12/2025Fox Run Management L.L.C.11,249$0.27M0.0%N/A0.013%Search for SEC Filing on Google Icon
11/10/2025Ameritas Investment Partners Inc.7,366$0.18M0.0%-13.4%0.008%Search for SEC Filing on Google Icon
11/10/2025Hillsdale Investment Management Inc.178,400$4.26M0.1%+9.2%0.199%Search for SEC Filing on Google Icon
11/10/2025China Universal Asset Management Co. Ltd.15,625$0.37M0.0%-12.4%0.017%Search for SEC Filing on Google Icon
11/7/2025Vanguard Group Inc.6,613,368$158.06M0.0%+10.3%7.392%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Travere Therapeutics logo
Travere Therapeutics, Inc., a biopharmaceutical company, identifies, develops, and delivers therapies to people living with rare kidney and metabolic diseases. Its products include FILSPARI (sparsentan), a once-daily, oral medication designed to target two critical pathways in the disease progression of IgA Nephropathy (endothelin 1 and angiotensin-II); and Thiola and Thiola EC (tiopronin tablets) for the treatment of cystinuria, a rare genetic cystine transport disorder that causes high cystine levels in the urine and the formation of recurring kidney stones. The company's clinical-stage programs consist of Sparsentan, a novel investigational product candidate, which has been granted Orphan Drug Designation for the treatment of focal segmental glomerulosclerosis in the U.S. and Europe; and Pegtibatinase (TVT-058), a novel investigational human enzyme replacement candidate being evaluated for the treatment of classical homocystinuria. It has a cooperative research and development agreement with National Institutes of Health's National Center for Advancing Translational Sciences and Alagille Syndrome Alliance for the identification of potential small molecule therapeutics for Alagille syndrome. The company was formerly known as Retrophin, Inc. and changed its name to Travere Therapeutics, Inc. in November 2020. Travere Therapeutics, Inc. was incorporated in 2008 and is headquartered in San Diego, California.
Read More on Travere Therapeutics

Today's Range

Now: $32.84
Low: $31.50
High: $33.01

50 Day Range

MA: $34.11
Low: $27.87
High: $40.60

52 Week Range

Now: $32.84
Low: $12.91
High: $42.13

Volume

1,748,186 shs

Average Volume

2,976,006 shs

Market Capitalization

$2.94 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.83

Who are the company insiders with the largest holdings of Travere Therapeutics?

Travere Therapeutics' top insider investors include:
  1. Eric M Dube (CEO)
  2. Peter Heerma (Insider)
  3. William E Rote (Insider)
  4. William E Rote (SVP)
  5. Christopher R Cline (CFO)
  6. Elizabeth E Reed (Insider)
  7. Jula Inrig (Insider)
  8. Jeffrey A Meckler (Director)
  9. Sandra Calvin (CAO)
  10. Timothy Coughlin (Director)
  11. Gary A Lyons (Director)
  12. Roy D Baynes (Director)
Learn More about top insider investors at Travere Therapeutics.

Who are the major institutional investors of Travere Therapeutics?

Travere Therapeutics' top institutional shareholders include:
  1. Vanguard Group Inc. — 7.05%
  2. Pictet Asset Management Holding SA — 0.60%
  3. Aberdeen Group plc — 0.58%
  4. UBS Group AG — 0.47%
  5. Assenagon Asset Management S.A. — 0.47%
  6. Jennison Associates LLC — 0.29%
Learn More about top institutional investors of Travere Therapeutics stock.

Which institutional investors are selling Travere Therapeutics stock?

In the previous quarter, TVTX stock was sold by these institutional investors:
  1. Jennison Associates LLC
  2. Aberdeen Group plc
  3. Vanguard Group Inc.
  4. Impax Asset Management Group plc
  5. UBS Group AG
  6. Pictet Asset Management Holding SA
  7. Universal Beteiligungs und Servicegesellschaft mbH
  8. Hussman Strategic Advisors Inc.
In the previous year, company insiders that have sold Travere Therapeutics company stock include:
  1. Eric M Dube (CEO)
  2. Peter Heerma (Insider)
  3. William E Rote (Insider)
  4. William E Rote (SVP)
  5. Christopher R Cline (CFO)
  6. Elizabeth E Reed (Insider)
  7. Jula Inrig (Insider)
  8. Jeffrey A Meckler (Director)
  9. Sandra Calvin (CAO)
  10. Timothy Coughlin (Director)
Learn More investors selling Travere Therapeutics stock.

Which institutional investors are buying Travere Therapeutics stock?

In the last quarter, TVTX stock was bought by institutional investors including:
  1. Assenagon Asset Management S.A.
  2. Palisades Investment Partners LLC
  3. Calamos Advisors LLC
  4. Hennion & Walsh Asset Management Inc.
  5. State of New Jersey Common Pension Fund D
  6. Assetmark Inc.
  7. M&T Bank Corp
  8. Concurrent Investment Advisors LLC